Exposure to hepatitis E virus (HEV) is common in the United
States (US) but there are few data on prevalence of HEV/HIV co-infection in US populations.
We tested
2,919 plasma samples collected from HIV-infected (HIV+)
women and men enrolled in US cohort studies for HEV viremia using a
high-throughput nucleic acid testing (NAT) platform. NAT+ samples
were confirmed by real-time polymerase chain reaction (PCR). Samples were
selected for testing primarily on the basis of biomarkers of liver disease and
immune suppression.
Prevalence of HEV viremia was 3/2,606 and 0/313 in tested
plasma samples collected from HIV+ women and men, respectively.
All HEV isolates
were genotype 3a. Based on follow-up testing of stored samples, one woman had
chronic HEV infection for >4 years while 2 women had acute HEV detectable at
only a single study visit.
CONCLUSION:
Purchase full article at: http://goo.gl/c8hhiy
By: Kuniholm MH1, Ong E2, Hogema BM3, Koppelman M3, Anastos K1,4, Peters MG5, Seaberg EC6, Chen Y7, Nelson KE6, Linnen JM2.
- 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
- 2Hologic, Inc., San Diego, CA, USA.
- 3Sanquin Research and Diagnostics, Departments of Virology, Blood-borne Infections and the National Screening Laboratory, Amsterdam, the Netherlands.
- 4Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.
- 5Department of Medicine, University of California, San Francisco, CA, USA.
- 6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- 7Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment